“Assessing Benefits and Risks of Hydroxychloroquine and Glucocorticoids in Systemic Lupus Erythematosus Treatment: Recommendations for Prudent Use”

https://pubmed.ncbi.nlm.nih.gov/38112074

The abstract discusses the benefits and risks of using hydroxychloroquine and glucocorticoids in the treatment of systemic lupus erythematosus, and provides recommendations for their judicious use, including stable doses of 200 mg/day for hydroxychloroquine and 5-2.5 mg/day for glucocorticoids in long-term maintenance treatments.